PPT-Canadian Cardiovascular Society

Antiplatelet Guidelines MANAGEMENT OF ANTIPLATELET THERAPY IN ASSOCIATION WITH MINOR BLEEDING Working Group James D Douketis MD FRCPC A Graham Turpie MD FRCPC Objectives Interpret the Canadian Cardiovascular Society . cshpca Acknowledgements The CHPRB Accreditation Standard 2010 draws heavily from works published by other pharmacy education and accreditation bodies including the Association of Facult ies of Pharmacy of Canada AFPC the Canadian Council for Accredit Antiplatelet Guidelines. PERIOPERATIVE MANAGEMENT OF ANTIPLATELET THERAPY. Working Group: . James D. Douketis MD, FRCP(C); A. Graham . Turpie. MD, FRCP(C). Objectives. Interpret the Canadian Cardiovascular Society . Antiplatelet Guidelines. Antiplatelet. Therapy for . Vascular Prevention in Patients with Peripheral Arterial Disease. Working. Group. : A. Roussin, MD, FRCP; Thomas F. Lindsay, MD, CM. , FRCSC. Objectives. Antiplatelet Guidelines. MANAGEMENT OF ANTIPLATELET THERAPY IN ASSOCIATION WITH MINOR BLEEDING. Working Group: . James D. Douketis MD, FRCP(C); A. Graham . Turpie. MD, FRCP(C). Objectives. Interpret the Canadian Cardiovascular Society . Antiplatelet Guidelines. USE OF ANTIPLATELET THERAPY IN WOMEN WHO ARE PREGNANT OR BREASTFEEDING. Working Group: . Wee . Shian. Chan MD, FRCP(C); James D. Douketis MD, FRCP(C). Antiplatelet. Guidelines. INTERACTION BETWEEN CLOPIDROGEL AND PROTON PUMP INHIBITORS. Working Group. : Wee Shian Chan, MD, FRCP; Alan D. Bell, MD, CCFP. Objectives. Interpret the . Canadian Cardiovascular Society . SZIMONETTA CSORTO & LOGAN . MaCDONALD. & Kyle . flynn. . This year the Canadian Cancer Society is hosting the first Annual Golf Fundraiser. This tournament includes:. A Shotgun start.. Food & Drinks . Antiplatelet Guidelines. HEART FAILURE. Working Group: . Alan D. Bell, MD, CCFP; James D. . Douketis. , MD, FRCP. Objectives. Interpret . the . Canadian Cardiovascular Society Guideline . recommendations . ASA – NSAID Drug/Drug Interaction. Working Group: . Alan D. Bell, MD, CCFP; Wee . Shian. Chan, MD, FRCP. Objectives. Interpret. . the . Canadian Cardiovascular Society Guideline recommendations regarding the use of antiplatelet therapy in patients . Antiplatelet Guidelines. . ANTIPLATELET THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE. Working. Group: . Neesh. . Pannu. , MD, SM, FRCP; Alan D. Bell, MD, CCFP. Interpret the Canadian Cardiovascular Society Guideline recommendations regarding the use antiplatelet . ASA – NSAID Drug/Drug Interaction. Working Group: . Alan D. Bell, MD, CCFP; Wee . Shian. Chan, MD, FRCP. Objectives. Interpret. . the . Canadian Cardiovascular Society Guideline recommendations regarding the use of antiplatelet therapy in patients . October 2018. Endorsed by the Canadian Association . of Emergency Physicians (CAEP). 2018 STEMI Guideline Authors. Graham C. Wong MD MPH (Co-Chair), Michelle Welsford MD, Craig Ainsworth MD, Wael Abuzeid MD MSc, Christopher Fordyce MDCM MHS MSc, Jennifer Greene BSc ACP, Thao Huynh MD MSc PhD, Laurie Lambert PhD, Michel Le May MD, Sohrab Lutchmedial MDCM, Shamir Mehta MD MSc, Madhu Natarajan MD MSc, Colleen Norris RN, MN, PhD, Christopher Overgaard MD MSc, Michele Perry . www.onlinecjc.com. ). .  . If your reuse request qualifies as medical institution internal education, you may reuse the material under the following conditions:. You must cite the Canadian Journal of Cardiology and the Canadian Cardiovascular Society as references.. www.onlinecjc.com. ).  . If your reuse request qualifies as medical institution internal education, you may reuse the material under the following conditions:. You . must cite the Canadian Journal of Cardiology and the Canadian .